Active substanceGinkgo biloba leaf extractGinkgo biloba leaf extract
Similar drugsTo uncover
  • Bilobil®
    capsules inwards 
  • Bilobil® intens 120
    capsules inwards 
  • Bilobil® forte
    capsules inwards 
  • Vitrum® Memori
    pills inwards 
    Unipharm, Inc.     USA
  • Gingium
    pills inwards 
    HEXAL AG     Germany
  • Ginkgo biloba
    capsules inwards 
    VERTEKS, AO     Russia
  • Ginkgo biloba
    pills inwards 
    PHARMACY 36.6, CJSC     Russia
  • Ginkgo biloba leaves extract dry
    raw materials.extract inwards 
    Linnea S.A.     Switzerland
  • Ginos®
    pills inwards 
    VEROPHARM SA     Russia
  • Memoplant
    pills inwards 
  • Memoplant
    pills inwards 
  • Tanacan®
    pills inwards 
    IPSEN PHARMA     France
  • Tanacan®
    solution inwards 
    IPSEN PHARMA     France
  • Dosage form: & nbspfilm coated tablets
    Composition:
    1 tablet, film-coated, contains:
    active substance: ginkgo bilobate leaves dry extract - 40 mg (standardized for the content of ginkgo-flavonoglycosides (24%) and terpenalactones);
    Excipients: lactose (milk sugar); corn starch; Povidone (polyvinylpyrrolidone 25,000); sodium carboxymethyl starch(Primogel); magnesium stearate; silicon dioxide colloid (aerosil); Shell: Opadrai II [hypromellose (gyroxypropylmethylcellulose), lactose monohydrate, crimson 4R dye (E 124), solar yellow dye (FD & C No. 6) (E 110), macrogol (polyethylene glycol 3350), triacetin, titanium dioxide].
    Description:

    Tablets, covered with a brick-red shell, round, biconvex.

    Pharmacotherapeutic group:Angioprotective agent of plant origin
    ATX: & nbsp

    N.06.D.X.02   Ginkgo Biloba Leaf Extract

    Pharmacodynamics:
    Biologically active substances extract leaves ginkgo biloba contribute to strengthening and increasing the elasticity of the vascular wall, improve the rheological properties of blood and as a result, improves microcirculation, supplying the brain and peripheral tissues with oxygen and glucose. The drug improves cerebral circulation, has cerebroprotective properties. Reduces the permeability of the vascular wall (anti-edematous effect - both at the level of the brain and at the periphery). The drug normalizes the metabolism in cells, prevents the aggregation of erythrocytes, inhibits the factor of platelet activation.Prevents the increase in fibrinolytic activity of the blood.
    Prevents formation of free radicals and peroxide oxidation of cell membrane lipids. Has a dose-dependent regulatory effect on the vascular system, dilates the small arteries, raises the tone of the veins, regulates blood vessels. The drug increases the body's resistance to hypoxia, especially brain tissue, inhibits the development of traumatic or toxic edema of the brain.
    Indications:
    • Dyscirculatory encephalopathy (stroke, craniocerebral trauma, old age), manifested by the following symptoms: decreased attention, memory loss, decreased intellectual ability, anxiety, dizziness, tinnitus, sleep disturbances.
    • Violations of peripheral circulation and microcirculation (including arteriopathy of the lower limbs), Raynaud's syndrome;
    • Neurosensory disorders, manifested by dizziness, ringing in the ears, unstable gait.
    Contraindications:

    Hypersensitivity to the extract of leaves of ginkgo biloba and other components of the drug, hypocoagulation, peptic ulcer of the stomach and duodenum in the acute stage,erosive gastritis, pregnancy, lactation period, children's age (up to 12 years), acute violation of cerebral circulation, acute myocardial infarction.

    Carefully:

    Arterial hypotension.

    Dosing and Administration:
    If the doctor did not recommend another dosing regimen, adhere to the following recommendations for taking the drug.
    For symptomatic treatment of disorders of cerebral circulation
    1-2 tablets 3 times a day. The duration of treatment is not less than 8 weeks.
    In cases of peripheral circulation disorders
    1 tablet 3 times a day. The duration of the course of treatment is 6-8 weeks.
    With neurosensory disorders
    1 tablet 3 times a day. Duration of treatment 6-8 weeks.
    Conducting repeated courses of treatment is possible after consulting a doctor.
    The tablets covered with a film cover, to accept inside, not liquid, squeezed a small amount of water. The drug should be taken in the morning, afternoon and evening, regardless of food intake.
    If the drug was missed or if an insufficient amount was taken, follow-up should be done as described in this manual without any changes.
    Side effects:Possible allergic reactions (skin rash, itching), gastrointestinal disorders (dyspepsia), decreased blood coagulation, headache, dizziness, insomnia.
    Overdose:At present, no cases of overdose have been reported.
    Interaction:It is not recommended to use Ginkgo biloba leaf extract to patients who are constantly taking acetylsalicylic acid and anticoagulants.
    Special instructions:
    Do not exceed the recommended dose of the drug.
    Improvement of the condition usually manifests itself 1 month after the start of treatment.
    If you suddenly experience a loss of hearing or hearing loss, you should immediately seek medical help. Consultation with a doctor is also necessary for frequent dizziness and tinnitus.
    It is not recommended to take Ginkgo biloba together with alcoholic beverages.
    Form release / dosage:
    Tablets, film-coated, 40 mg.
    Packaging:
    For 10 tablets in a planar cell package. For 20 or 30 tablets in a bank of light-protective glass; or 20 or 30 tablets in a can of polymer, or a vial of polymer.
    Each jar or bottle, 2, 3, 5, 9 or 10 contour squares together with the instruction for use is placed in a pack of cardboard.
    A polymer can or polymer bottle without bundles is supplied with adhesive instruction for use and placed in a group package.
    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C. Keep out of the reach of children.

    Shelf life:2 years. Do not use after expiry date.
    Terms of leave from pharmacies:On prescription
    Registration number:LSR-002517/07
    Date of registration:31.08.2007
    Expiration Date:Unlimited
    The owner of the registration certificate:PHARMACY 36.6, CJSC PHARMACY 36.6, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp16.04.2017
    Illustrated instructions
      Instructions
      Up